EXHIBIT 10.6 DENDREON CORPORATION SERIES E PREFERRED STOCK PURCHASE AGREEMENT September 3, 1999 TABLE OF CONTENTSPurchase Agreement • March 8th, 2000 • Dendreon Corp • California
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF DENDREON CORPORATIONDendreon Corp • March 8th, 2000
Exhibit 1.1 Dendreon Corporation [.] Shares/1/ Common Stock FORM OF UNDERWRITING AGREEMENT ------------------------------ Prudential Securities Incorporated SG Cowen Securities Corporation Pacific Growth Equities, Inc. As Representatives of the...Dendreon Corp • June 15th, 2000 • Pharmaceutical preparations • New York
Exhibit 1.1 Dendreon Corporation 2,500,000 Shares/1/ Common Stock FORM OF UNDERWRITING AGREEMENT ---------------------- October __, 2000 Prudential Securities Incorporated SG Cowen Securities Corporation Pacific Growth Equities, Inc. As...Underwriting Agreement • October 25th, 2000 • Dendreon Corp • Pharmaceutical preparations • New York
RECITALSStock Purchase Agreement • October 11th, 2000 • Dendreon Corp • Pharmaceutical preparations • Delaware
RECITALSIndemnity Agreement • December 19th, 2006 • Dendreon Corp • Pharmaceutical preparations • Delaware
EXHIBIT 10.5 DENDREON CORPORATION SERIES D PREFERRED STOCK PURCHASE AGREEMENTPurchase Agreement • March 8th, 2000 • Dendreon Corp • California
Customer No. 1080 AMENDED AND RESTATED MASTER LEASE AGREEMENT Lessor: TRANSAMERICA BUSINESS CREDIT CORPORATION Riverway II West Office Tower West Higgins Rosemont, Illinois 60018 Lessee: DENDREON CORPORATION 3005 First Avenue Seattle, Washington 98121...Master Lease Agreement • March 8th, 2000 • Dendreon Corp • Illinois
ARTICLE I --------- PARTIES -------Dendreon Corp • March 8th, 2000 • California
DENDREON CORPORATION and MELLON INVESTOR SERVICES LLC as Rights Agent RIGHTS AGREEMENT Dated as of September 18, 2002Rights Agreement • September 25th, 2002 • Dendreon Corp • Pharmaceutical preparations • Delaware
THIS RIGHTS AGREEMENT (“Agreement”), dated as of September 18, 2002, is entered into between DENDREON CORPORATION, a Delaware corporation (the “Company”), and MELLON INVESTOR SERVICES LLC, a New Jersey limited liability company, as Rights Agent (“Rights Agent”).
WITNESSETH:Voting Agreement • February 25th, 2003 • Dendreon Corp • Pharmaceutical preparations • Delaware
Common StockPlacement Agent Agreement • November 16th, 2006 • Dendreon Corp • Pharmaceutical preparations • New York
BETWEENManufacturing and Supply Agreement • March 14th, 2003 • Dendreon Corp • Pharmaceutical preparations
INDEMNITY AGREEMENTIndemnity Agreement • August 17th, 2005 • Dendreon Corp • Pharmaceutical preparations • Delaware
THIS AGREEMENT is made and entered into this 15th day of August, 2005 by and between Dendreon Corporation, a Delaware corporation (the “Corporation”), and Michelle Burris (“Agent”).
Registration Rights Agreement Dated as of June 11, 2007 among Dendreon Corporation and Merrill Lynch, Pierce, Fenner & Smith IncorporatedRegistration Rights Agreement • June 12th, 2007 • Dendreon Corp • Pharmaceutical preparations • New York
This Agreement is made pursuant to the Purchase Agreement, dated as of June 5, 2007, among the Company and the Initial Purchaser (the “Purchase Agreement”), which provides for the sale by the Company to the Initial Purchaser of $75,000,000 aggregate principal amount ($100,000,000 principal amount if the Initial Purchaser exercises its option in full) of the Company’s 4.75% Convertible Senior Subordinated Notes due 2014 (the “Securities”). In order to induce the Initial Purchaser to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement.
Exhibit 99.1 DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (WASHINGTON STATE) This Executive Employment Agreement ("AGREEMENT") is entered into as of the date of the last signature to this Agreement ("EFFECTIVE DATE"), by and between Dendreon...Executive Employment Agreement • January 4th, 2007 • Dendreon Corp • Pharmaceutical preparations • Washington
DENDREON CORPORATION 10,250,000 Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • January 27th, 2004 • Dendreon Corp • Pharmaceutical preparations • New York
Dendreon Corporation Common Stock UNDERWRITING AGREEMENT dated December 6, 2005 Banc of America Securities LLCUnderwriting Agreement • December 7th, 2005 • Dendreon Corp • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AND SHAREHOLDER'S AGREEMENTDendreon Corp • March 8th, 2000 • New York
OFFICE LEASE AGREEMENT BY AND BETWEEN WELLS REIT – BRIDGEWATER NJ, LLC, as the Landlord AND DENDREON CORPORATION, as the Tenant Bridgewater Crossing 200 Crossing Boulevard Bridgewater, New JerseyOffice Lease Agreement • July 31st, 2012 • Dendreon Corp • Pharmaceutical preparations
THIS OFFICE LEASE AGREEMENT (hereinafter referred to as this “Lease”) is dated as of the 29 day of June, 2012, by and between WELLS REIT – BRIDGEWATER NJ, LLC, a Delaware limited liability company (hereinafter referred to as the “Landlord”), and DENDREON CORPORATION, a Delaware corporation, on behalf of itself and its Affiliates (hereinafter referred to as the “Tenant”).
Exhibit 10.19 RESEARCH COLLABORATION AND LICENSE AGREEMENT This Research Collaboration And License Agreement (the "Agreement") is made by and between The R. W. Johnson Pharmaceutical Research Institute, a division of Ortho-McNeil Pharmaceutical, Inc.,...Collaboration and License Agreement • October 25th, 2000 • Dendreon Corp • Pharmaceutical preparations • California
RecitalsIndemnity Agreement • March 8th, 2000 • Dendreon Corp • Delaware
DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (WASHINGTON STATE)Executive Employment Agreement • August 17th, 2005 • Dendreon Corp • Pharmaceutical preparations • Washington
This Executive Employment Agreement (“Agreement”) is entered into as of the date of the last signature to this Agreement (“Effective Date”), by and between Dendreon Corporation, a Delaware corporation (the “Company”), and Michelle Burris (“Employee”).
EXHIBIT 10.16 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • March 8th, 2000 • Dendreon Corp • California
EXHIBIT 99.1 For Approval by the Board DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (WASHINGTON STATE) This Executive Employment Agreement ("AGREEMENT") is entered into as of the date of the last signature to this Agreement ("EFFECTIVE DATE"),...Employment Agreement • December 19th, 2006 • Dendreon Corp • Pharmaceutical preparations • Washington
RecitalsStockholders' Agreement • March 8th, 2000 • Dendreon Corp • Delaware
MASTER SECURITY AGREEMENT dated as of December 30, 2005 (“Agreement”)Master Security Agreement • January 5th, 2006 • Dendreon Corp • Pharmaceutical preparations
THIS AGREEMENT is between General Electric Capital Corporation (together with its successors and assigns, if any, “Secured Party”) and Dendreon Corporation (“Debtor”). Secured Party has an office at 83 Wooster Heights Road, Danbury, CT 06810. Debtor is a corporation organized and existing under the laws of the state of Delaware (“the State”). Debtor’s mailing address and chief place of business is 3005 1st Avenue, Seattle, WA, 98121.
Customer No. 1080 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT dated as of July 30, 1999, is made by Dendreon Corporation (the "Borrower"), a Delaware corporation having its principal place of business and chief executive office at...Loan and Security Agreement • March 8th, 2000 • Dendreon Corp • Illinois
DENDREON CORPORATION, as the Company and THE BANK OF NEW YORK TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of June 9, 2008 DEBT SECURITIESIndenture • June 11th, 2008 • Dendreon Corp • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of June 9, 2008, between Dendreon Corporation, a Delaware corporation (the “Company”), and The Bank of New York Trust Company, N.A., a national banking association (the “Trustee”);
DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 30th, 2014 • Dendreon Corp • Pharmaceutical preparations • New Jersey
This Executive Employment Agreement (this “Agreement”) is effective as of July 28, 2014 (“Effective Date”), by and between Dendreon Corporation, a Delaware corporation (the “Company”), and W. Thomas Amick (“Employee”).
Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. (S)(S) 200.80(b)(4), 200.83 and 240.24b-2 MONONUCLEAR CELL COLLECTION SERVICES AGREEMENTCollection Services Agreement • March 26th, 2002 • Dendreon Corp • Pharmaceutical preparations • Washington
BETWEENCollaborative License Agreement • May 22nd, 2000 • Dendreon Corp • Pharmaceutical preparations • California
CONSTRUCTION MANAGEMENT AGREEMENT Between DENDREON CORPORATION Owner, And TURNER CONSTRUCTION COMPANY Construction Manager. Project: 1700 Saturn Drive Seal Beach, California As of December 2009Construction Management Agreement • February 22nd, 2010 • Dendreon Corp • Pharmaceutical preparations • New York
AGREEMENT, made as of the 9thday of December, 2009, by and between Dendreon Corporation, as Owner, having its principal place of business at 3005 First Avenue, Seattle, Washington 98121 (“Owner”), and Turner Construction Company, having an office at 1900 South State College Blvd., Suite 200, Anaheim, California 92806 (“Construction Manager”).
DENDREON CORPORATION STOCK OPTION AGREEMENT NONSTATUTORY STOCK OPTIONSStock Option Agreement • June 13th, 2005 • Dendreon Corp • Pharmaceutical preparations
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Dendreon Corporation (the “Company”) has granted you an option under its 2002 Broad Based Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
CORVAS INTERNATIONAL, INC. AMENDED AND RESTATED 5.5% CONVERTIBLE SENIOR SUBORDINATED NOTE DUE 2006Dendreon Corp • September 17th, 2003 • Pharmaceutical preparations • California
This Amended and Restated 5.5% Convertible Senior Subordinated Note (this “Note”), dated as of July 22, 2003, amends, re-evidences, restates, and supercedes in full, but does not in any way waive, satisfy or discharge the outstanding indebtedness, if any, or any other obligation owed under, nor does it in any way limit the rights granted under, that certain 5.5% Convertible Senior Subordinated Note dated August 18, 1999 in the original principal amount of Six Million Five Hundred Thousand Dollars ($6,500,000) made by the undersigned (the “Company”) in favor of ARTISAN EQUITY LIMITED, a Bermuda company, or its registered assigns (the “Holder”).
